GORDON J RAFOOL, MD
Osteopathic Medicine at 1 St, Winter Haven, FL

License number
Florida ME18395
Category
Osteopathic Medicine
Type
Family Medicine
License number
Florida ME18395
Category
Osteopathic Medicine
Type
Geriatric Medicine
Address
Address
635 1St St N, Winter Haven, FL 33881
Phone
(863) 294-0670
(863) 298-3200 (Fax)

Personal information

See more information about GORDON J RAFOOL at radaris.com
Name
Address
Phone
Gordon Rafool
635 1St St N, Winter Haven, FL 33881
(813) 899-9808
Gordon Rafool
800 NW Peacock Blvd #71, Port St Lucie, FL 34986
Gordon D Rafool, age 78
635 1St St, Winter Haven, FL 33881
(863) 294-7456
(863) 294-0670
Gordon J Rafool, age 81
229 Durrell Rd, Winter Haven, FL 33884
Gordon J Rafool, age 81
301 Hamilton Shores Dr NE, Winter Haven, FL 33881
(863) 294-4542

Organization information

See more information about GORDON J RAFOOL at bizstanding.com

Gessler Clinic - Gordon J Rafool MD

635 1 St N, Winter Haven, FL 33881

Categories:
Family & General Practice Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Physicians & Surgeons
Phone:
(863) 298-3383 (Phone)
In business since:
1957
Products:
Family Practice, Pain Management, Pediatrics, ...

Professional information

See more information about GORDON J RAFOOL at trustoria.com
Gordon J Rafool Photo 1
Dr. Gordon J Rafool, Winter Haven FL - MD (Doctor of Medicine)

Dr. Gordon J Rafool, Winter Haven FL - MD (Doctor of Medicine)

Specialties:
Geriatric Medicine
Address:
635 1St St N, Winter Haven 33881
(863) 294-0670 (Phone)
Certifications:
Family Practice, 1992, Geriatric Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
635 1St St N, Winter Haven 33881
Regency Medical Center
101 Avenue O South #East, Winter Haven 33880
Winter Haven Hospital
200 Avenue F North #East, Winter Haven 33881
Education:
Medical School
Medical College Of Georgia School Of Medicine
Graduated: 1968
St Francis Hospital
Osf St Francis Med Center


Gordon Rafool Photo 2
Levo-Monosaccharide In A Nucleoside Analog For Use As An Anti-Retroviral Agent

Levo-Monosaccharide In A Nucleoside Analog For Use As An Anti-Retroviral Agent

US Patent:
6090602, Jul 18, 2000
Filed:
Feb 18, 1998
Appl. No.:
9/025530
Inventors:
Timothy N. Tillman - Winter Haven FL
Daryl L. Thompson - Winter Haven FL
Gordon J. Rafool - Winter Haven FL
Assignee:
Promelas Research Corporation - Winter Haven FL
International Classification:
C12N 900, C12N 1563, C07H 2104
US Classification:
435183
Abstract:
An antiretroviral composition for inhibiting the action of reverse transcriptase include a nucleoside analog containing a six-carbon levo hexose sugar, for example, L-rhamnose or L-fucose. Treatment is achieved by delivering the antiretroviral to the infected system, wherein the reverse transcription process is inhibited via steric hindrance, halting the viral RNA replication. Delivery may be accomplished by conventional methods, such as via oral dosing or injection. Additional delivery methods are also contemplated, including packaging in liposomes and protein targeting. The composition and method are also useful for inhibiting the proliferation of cancer cells by halting the transcription process.


Gordon J Rafool Photo 3
Gordon J Rafool, Winter Haven FL

Gordon J Rafool, Winter Haven FL

Specialties:
Family Physician
Address:
635 1St St N, Winter Haven, FL 33881
Education:
Medical College of Georgia, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Family Medicine Certification in Family Medicine


Gordon Rafool Photo 4
Composition And Method For Inhibiting Reverse Transcript Of A Retrovirus

Composition And Method For Inhibiting Reverse Transcript Of A Retrovirus

US Patent:
6319711, Nov 20, 2001
Filed:
Jun 28, 2000
Appl. No.:
9/605817
Inventors:
Timothy N. Tillman - Winter Haven FL
Daryl L. Thompson - Winter Haven FL
Gordon J. Rafool - Winter Haven FL
Assignee:
Promelas Research Corporation - Winter Haven FL
International Classification:
C12N 900, C12N 1563, C07H 2104
US Classification:
4353723
Abstract:
An antiretroviral composition for inhibiting the action of reverse transcriptase include a nucleoside analog containing a six-carbon levo hexose sugar, for example, L-rhamnose or L-fucose. Treatment is achieved by delivering the antiretroviral to the infected system, wherein the reverse transcription process is inhibited via steric hindrance, halting the viral RNA replication. Delivery may be accomplished by conventional methods, such as via oral dosing or injection. Additional delivery methods are also contemplated, including packaging in liposomes and protein targeting. The composition and method are also useful for inhibiting the proliferation of cancer cells by halting the transcription process.